
Bharat Immunological & Biologicals Corporation Share Price
₹24.93 -0.27 (-1.07%)
09 Feb, 2025 01:50
Start SIP in
BIBCL
Performance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume0
Investment Returns
- Over 1 Month -22.89%
- Over 3 Month -3.78%
- Over 6 Month -19.35%
- Over 1 Year -38.35%
Smart Investing Starts Here Start SIP with Bharat Immunological & Biologicals Corporation for Steady Growth!
Bharat Immunological & Biologicals Corporation Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Bharat Immunological & Biologicals Corporation Financials
Bharat Immunological & Biologicals Corporation Technicals
EMA & SMA
Current Price
₹24.93
-0.27
(-1.07%)

-
- Bearish Moving Average 16
-
- Bullish Moving Average 0
- 20 Day
- ₹25.45
- 50 Day
- ₹25.49
- 100 Day
- ₹26.03
- 200 Day
- ₹27.00
Resistance and Support
24.98
- R3 26.15
- R2 25.78
- R1 25.35
- S1 24.55
- S2 24.18
- S3 23.75
Bharat Immunological & Biologicals Corporation Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-08-16 | General Purpose. | |
2024-03-08 | Others | General Purpose |
2023-10-31 | Quarterly Results | |
2023-04-24 | Audited Results | |
2023-02-09 | Quarterly Results |
Bharat Immunological & Biologicals Corporation F&O
About Bharat Immunological & Biologicals Corporation
- NSE Symbol
- BIBCL
- BSE Symbol
- 524663
- ISIN
- INE994B01014
Similar Stocks to Bharat Immunological & Biologicals Corporation
Bharat Immunological & Biologicals Corporation FAQs
Bharat Immunological & Biologicals Corporation share price is ₹24 As on 09 February, 2025 | 01:36
The Market Cap of Bharat Immunological & Biologicals Corporation is ₹107.6 Cr As on 09 February, 2025 | 01:36
The P/E ratio of Bharat Immunological & Biologicals Corporation is -5.8 As on 09 February, 2025 | 01:36
The PB ratio of Bharat Immunological & Biologicals Corporation is 1.2 As on 09 February, 2025 | 01:36
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.